Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases

NCT ID: NCT05930444

Last Updated: 2024-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9825 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-21

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With rapid advancements in natural language processing and image processing, there is a growing potential for intelligent diagnosis utilizing chatGPT trained through high-quality ophthalmic consultation. Furthermore, by incorporating patient selfies, eye examination photos, and other image analysis techniques, the diagnostic capabilities can be further enhanced. The multi-center study aims to develop an auxiliary diagnostic program for eye diseases using multimodal machine learning techniques and evaluate its diagnostic efficacy in real-world outpatient clinics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eye Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal participants

Healthy individuals who have no concerns related to their eyes.

No interventions assigned to this group

Patients with Eye-related Chief Complaints

Individuals who have specific concerns or issues related to their eyes, which they consider as the main reason for seeking medical attention or making a complaint.

Multimodal Machine Learning Program for Auxiliary Diagnosis of Eye Diseases

Intervention Type DIAGNOSTIC_TEST

Patients presenting with eye-related chief complaints initially complete a mobile phone application. This application utilizes patient medical history and relevant images (such as selfies and photos from eye examinations) to provide intelligent diagnosis. The diagnosis remains undisclosed to the patients. Subsequently, patients seek medical attention and undergo clinical examination by a skilled clinician. The clinical diagnosis is subsequently reviewed by a second experienced clinician. If the diagnoses align, it is considered the gold standard. In cases of discrepancy, the consensus reached by the two clinicians becomes the gold standard.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multimodal Machine Learning Program for Auxiliary Diagnosis of Eye Diseases

Patients presenting with eye-related chief complaints initially complete a mobile phone application. This application utilizes patient medical history and relevant images (such as selfies and photos from eye examinations) to provide intelligent diagnosis. The diagnosis remains undisclosed to the patients. Subsequently, patients seek medical attention and undergo clinical examination by a skilled clinician. The clinical diagnosis is subsequently reviewed by a second experienced clinician. If the diagnoses align, it is considered the gold standard. In cases of discrepancy, the consensus reached by the two clinicians becomes the gold standard.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent obtained;
* Participants should be able to have Chinese as their mother tongue, and be sufficiently able to read, write and understand Chinese;
* For normal participants: individuals should have no concerns related to their eyes.
* For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes.

Exclusion Criteria

* Incomplete clinical data to support final diagnosis;
* Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.
Minimum Eligible Age

2 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Affiliated Eye Hospital of Nanjing Medical University

UNKNOWN

Sponsor Role collaborator

Suqian First Hospital

OTHER

Sponsor Role collaborator

Eye & ENT Hospital of Fudan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Affiliated Eye Hospital of Nanjing Medical University

Nanjing, , China

Site Status

Fudan Eye & ENT Hospital

Shanghai, , China

Site Status

Suqian First People's Hospital

Suqian, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Ma R, Cheng Q, Yao J, Peng Z, Yan M, Lu J, Liao J, Tian L, Shu W, Zhang Y, Wang J, Jiang P, Xia W, Li X, Gan L, Zhao Y, Zhu J, Qin B, Jiang Q, Wang X, Lin X, Chen H, Zhu W, Xiang D, Nie B, Wang J, Guo J, Xue K, Cui H, Cheng J, Zhu X, Hong J, Shi F, Zhang R, Chen X, Zhao C. Multimodal machine learning enables AI chatbot to diagnose ophthalmic diseases and provide high-quality medical responses. NPJ Digit Med. 2025 Jan 27;8(1):64. doi: 10.1038/s41746-025-01461-0.

Reference Type DERIVED
PMID: 39870855 (View on PubMed)

Peng Z, Ma R, Zhang Y, Yan M, Lu J, Cheng Q, Liao J, Zhang Y, Wang J, Zhao Y, Zhu J, Qin B, Jiang Q, Shi F, Qian J, Chen X, Zhao C. Development and evaluation of multimodal AI for diagnosis and triage of ophthalmic diseases using ChatGPT and anterior segment images: protocol for a two-stage cross-sectional study. Front Artif Intell. 2023 Dec 8;6:1323924. doi: 10.3389/frai.2023.1323924. eCollection 2023.

Reference Type DERIVED
PMID: 38145231 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://pubmed.ncbi.nlm.nih.gov/38145231/

Development and evaluation of multimodal AI for diagnosis and triage of ophthalmic diseases using ChatGPT and anterior segment images: protocol for a two-stage cross-sectional study

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FD-EENT-20230625

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.